Unresectable Solid Tumors
📧 Sign up to get email alerts when something new happens for Unresectable Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors [Phase 1]
A Phase 1 trial by the National Cancer Institute is evaluating the combination of Peposertib (M3814) and Tuvusertib (M1774) in patients with…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of nivolumab and ipilimumab in adults with HIV-associated relapsed or refractory classical Hodgkin …
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma [Phase 1]
This Phase 1 clinical trial update assesses the safety of combining SBRT with an anti-PD-1 therapy (nivolumab) and an anti-IL-8 agent. The s…